Abstract
Sanofi Pasteur shows efficacy of its dengue vaccine in phase 3
New glioblastoma vaccine: Safe and immunogenic in phase 1
FDA approves sublingual hay fever immunotherapeutic
Combining the cancer vaccine DPX-Survivac with immune modulators
Two Meningococcal B vaccines receive FDA "Breakthrough Therapy" designation
MERS vaccine is technically feasible, but is it commerically feasible?
Stemline’s synthetic multi-peptide cancer vaccine enters Phase 2
Evolution of whooping cough bacterium may reduce vaccine effectiveness